secwatch.observer — SEC 8-K summary
======================================

Issuer:     DEXCOM INC (DXCM)
CIK:        0001093557
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001093557-22-000170
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dexcom Q3 revenue $769.6M (+18% YoY); non-GAAP EPS $0.28; guides FY22 ~$2.88-2.91B
--------------------------------------------------------------------------------

- Revenue $769.6M, up 18% reported, 20% organic; US +17%, international +22% reported (+28% organic).
- GAAP net income $101.2M ($0.24 EPS); non-GAAP net income $111.9M ($0.28 EPS).
- Non-GAAP operating margin 20.9% (up 190 bps YoY); GAAP operating income $147.5M.
- Initiated international rollout of Dexcom G7 in UK, Ireland, Germany, Austria, Hong Kong.
- FY22 revenue guidance updated to ~$2.88-2.91B (18-19% growth); non-GAAP operating margin ~16%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000170/0001093557-22-000170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1093557/000109355722000170/dxcm-20221027.htm
  HTML page:      https://secwatch.observer/filing/0001093557-22-000170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer